Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Core Laboratories Inc.

D4t4 Solutions (($GB:CLBS)) has held its Q2 earnings call. Read on for the main highlights of the call. The recent earnings call for D4t4 Solutions...

D4t4 Solutions Earnings Call: Mixed Outlook with Growth Potential

Canaccord Genuity analyst Kai Korschelt maintained a Buy rating on Celebrus Technologies today and set a price target of p280.00. According to TipR...

Canaccord Genuity Remains a Buy on Celebrus Technologies (CLBS)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Cellebrite DI (CLBT – Research Report) and Aeva Te...

Analysts Conflicted on These Technology Names: Cellebrite DI (CLBT) and Aeva Technologies (AEVA)

In a report released today, Eric Martinuzzi from Lake Street maintained a Buy rating on Cellebrite DI, with a price target of $23.00. Martinuzzi co...

Lake Street Sticks to Its Buy Rating for Cellebrite DI (CLBT)

Cellebrite DI ( ($CLBT) ) has shared an announcement. On December 1, 2025, Cellebrite DI Ltd. completed its acquisition of Corellium, a leader in A...

Cellebrite Completes Acquisition of Corellium, Enhancing Digital Investigation Platform

The latest update is out from ANGLE plc ( ($GB:CLBX) ). CelLBxHealth plc has successfully closed its Retail Offer, raising approximately £0.96 mill...

CelLBxHealth plc Successfully Closes Retail Offer, Raising £0.96 Million

An announcement from ANGLE plc ( ($GB:CLBX) ) is now available. CelLBxHealth plc announced an update regarding the admission of fundraising shares ...

CelLBxHealth Announces Update on Fundraising Shares Admission

ANGLE plc ( ($GB:CLBX) ) has issued an update. CelLBxHealth plc has announced a proposed fundraising of £6.8 million through a placing, subscriptio...

CelLBxHealth Announces £6.8 Million Fundraising to Drive Commercial Strategy

In a report released today, Mark Fitzgibbon from Piper Sandler maintained a Hold rating on Columbia Financial, with a price target of $17.00. Fitzg...

Market Cap	$782.26M	P/E Ratio	21.97
52W High	$20.82	52W Low	$9.72
Div Yield	4.0%	Payout Ratio	12.4%
EPS Growth 3Y	15.0%	52W Position	60.9%
Overall Score	61	Value Score	80
Quality Score	39	Technical Score	66

EPS Current Est	$0.75	EPS Next Est	$0.79
EPS Growth Est	+5.3%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLB	$16.48	-3.12%	365.81K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CLB	$16.48	-3.1%	365.81K
3
4
5
6

CLB

CLB

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Core Laboratories Inc. Data in Excel

Get Core Laboratories Inc. Data in Excel